COMPARISON OF PEDIATRIC PATIENTS AND YOUNG ADULTS WITH MODERATELY TO SEVERELY ACTIVE CROHN'S DISEASE TREATED WITH USTEKINUMAB IN THE REALITI REAL-WORLD EVIDENCE EFFECTIVENESS STUDY

被引:0
|
作者
Steiner, Steven
Saeed, Shezad A.
Adler, Jeremy
Colletti, Richard B.
Strauss, Richard
Heile, J. M.
Adedokun, Omoniyi J.
Sheahan, Anna
Zhang, Renping
Lo, Kim H.
Kim, Lilianne
Xiao, Yongling
Volger, Sheri
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Mo2040
引用
收藏
页码:S1208 / S1208
页数:1
相关论文
共 50 条
  • [31] Safety of Ustekinumab With and Without Concomitant Corticosteroids or Immunosuppressants in Patients With Moderately to Severely Active Crohn's Disease
    Sands, Bruce E.
    Gasink, Christopher
    Jacobstein, Douglas
    Ott, Elyssa
    Lang, Yinghua
    Ramachandran, Paraneedharan
    Ghosh, Subrata
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S329 - S330
  • [32] An Australian Real-World Study of Treatment Persistence of Ustekinumab in Crohn's Disease
    Chien, Tzu Hsiang
    Puig, Andrea
    Khuong, Thang
    Kouhkamari, Mahsa H.
    Che, Samuel
    Huang, Tom Hsun-Wei
    BIOLOGICS-TARGETS & THERAPY, 2021, 15 : 237 - 245
  • [33] Ustekinumab treatment persistence in Crohn's disease: An Australian real-world study
    Chien, T. H.
    Huang, Th-W
    Puig, A.
    Khuong, T.
    Kouhkamari, M. H.
    Che, S.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 : 91 - 91
  • [34] Population Pharmacokinetics and Exposure-Response Analyses of Ustekinumab in Patients With Moderately to Severely Active Crohn's Disease
    Adedokun, Omoniyi J.
    Xu, Zhenhua
    Gasink, Christopher
    Kowalski, Ken
    Sandborn, William J.
    Feagan, Brian
    CLINICAL THERAPEUTICS, 2022, 44 (10) : 1336 - 1355
  • [35] Safety of Ustekinumab With and Without Concomitant Corticosteroids or Immunosuppressants in Patients With Moderately-to-Severely Active Crohn's Disease
    Bruce, Sands
    Christopher, Gasink
    Douglas, Jacobstein
    Elyssa, Ott
    Lang Yinghua
    Paraneedharan, Ramachandran
    Subrata, Ghosh
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S24 - S24
  • [36] Ustekinumab in paediatric patients with moderately to severely active Crohn's disease: UniStar study long-term extension results
    Turner, Dan
    Rosh, Joel R.
    Cohen, Stanley A.
    Griffiths, Anne M.
    Hyams, Jeffrey S.
    Kierkus, Jaroslaw
    Adedokun, Omoniyi J.
    Strauss, Richard
    Kim, Lilianne
    Volger, Sheri
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2024, 79 (02): : 315 - 324
  • [37] Real-world effectiveness and safety of ustekinumab induction therapy for Korean patients with Crohn's disease: a KASID prospective multicenter study
    Oh, Kyunghwan
    Hong, Hee Seung
    Ham, Nam Seok
    Lee, Jungbok
    Park, Sang Hyoung
    Yang, Suk-Kyun
    Yoon, Hyuk
    Kim, You Sun
    Choi, Chang Hwan
    Ye, Byong Duk
    INTESTINAL RESEARCH, 2022, : 137 - 147
  • [38] Real-world clinical effectiveness of ustekinumab in the treatment of Crohn's disease in the East Midlands UK
    White, Jonathan Richard
    Ahmad, Saqib
    Ashraf, Fahad
    Foley, Stephen
    Din, Said
    Das, Ronit Kumar
    Charles, Nina Mary
    Pinheiro, Joao
    Palejwala, Altaf
    Wright, Pamela
    Andiappan, Manoharan
    Alexander, Myriam
    Uddin, Burhan
    Hoshen, Deloar
    Elphick, David
    Qamar, Tufail
    Rezwan, Nivin
    Hamza, Mohammad Viquaruddin
    Glover, John
    Robinson, Richard
    Gopakumar, Veena
    Sajjad, Aamir
    Shahzad, Muhammad
    Moran, Gordon
    FRONTLINE GASTROENTEROLOGY, 2024, 15 (05) : 359 - 365
  • [39] Long-term real-world data of ustekinumab in Crohn's disease: the Stockholm ustekinumab study
    Bello, Francesca
    Muhsen, Samer
    Sabhan, Haider
    Borin, Alexandra
    Johansson, Fredrik
    Hoog, Charlotte
    Forsberg, Ole
    Wennerstrom, Christina
    Soderman, Charlotte
    Lordal, Mikael
    Almer, Sven
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2024, 17
  • [40] Effectiveness and Safety of Ustekinumab in Elderly Patients with Crohn's Disease: Real World Evidence From the ENEIDA Registry
    Casas-Deza, Diego
    Lamuela-Calvo, Luis Javier
    Gomollon, Fernando
    Arbones-Mainar, Jose Miguel
    Caballol, Berta
    Gisbert, Javier P.
    Rivero, Montserrat
    Sanchez-Rodriguez, Eugenia
    Arias Garcia, Lara
    Gutierrez Casbas, Ana
    Merino, Olga
    Marquez, Lucia
    Laredo, Viviana
    Martin-Arranz, Maria Dolores
    Lopez Serrano, Pilar
    Riestra Menendez, Sabino
    Gonzalez-Munoza, Carlos
    de Castro Parga, Luisa
    Calvo Moya, Marta
    Fuentes-Valenzuela, Esteban
    Esteve, Maria
    Iborra, Marisa
    Dura Gil, Miguel
    Barreiro-De Acosta, Manuel
    Lorente-Poyatos, Rufo Humberto
    Mancenido, Noemi
    Calafat, Margalida
    Rodriguez-Lago, Iago
    Guardiola Capo, Jordi
    Antonia Payeras, Maria
    Morales Alvarado, Victor Jair
    Tardillo, Carlos
    Bujanda, Luis
    Munoz-Nunez, Jose Fernando
    Ber Nieto, Yolanda
    Bermejo, Fernando
    Almela, Pedro
    Navarro-Llavat, Merce
    Martinez Montiel, Pilar
    Rodriguez Gutierrez, Cristina
    Van Domselaar, Manuel
    Sese, Eva
    Martinez Perez, Teresa
    Ricart, Elena
    Chaparro, Maria
    Jose Garcia, Maria
    Lopez-Sanroman, Antonio
    Sicilia, Beatriz
    Orts, Beatriz
    Lopez-Garcia, Alicia
    JOURNAL OF CROHNS & COLITIS, 2023, 17 (01): : 83 - 91